Clinical Trials Logo

Cognitive Dysfunction clinical trials

View clinical trials related to Cognitive Dysfunction.

Filter by:

NCT ID: NCT05768620 Completed - Clinical trials for Mild Cognitive Impairment

Active Navigation Training

ANTaging
Start date: April 1, 2020
Phase: N/A
Study type: Interventional

Pilot testing and development of an immersive virtual reality system for spatial navigation training in mild cognitive impairment syndrome.

NCT ID: NCT05764421 Completed - MCI Clinical Trials

Motor-cognitive Interventions Are Effective in Improving Cognitive Function in Older Adults With Mild Cognitive impairment--a Chinese Sample

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

Mild cognitive impairment (MCI) is a syndrome that occurs in the preclinical stage of Alzheimer, and early intervention can be effective in preventing Alzheimer, but further research is needed on intervention methods. In order to identify interventions that are more suitable for Chinese characteristics and to investigate the effects of a motor-cognitive intervention on the cognitive function of older adults with MCI, investigators screened 103 community-dwelling older adults with MCI aged 65 years and older in Qingdao, Shandong, China, and divided them into an intervention group and a control group, and administered a motor-cognitive intervention to the intervention group for 12 weeks. Investigators assessed the cognitive abilities of MCI participants using the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA). There were no demographic differences between the intervention and control groups. Investigators found that the cognitive abilities of the intervention group were significantly improved at the end of the intervention as well as at the end of the follow-up compared to the control group. The results of the current study suggest that the motor-cognitive intervention investigators used significantly improved cognitive function in older adults with MCI and was easy for older adults to master, and that it was a good intervention for cognitive function in older adults with MCI in the Chinese community.

NCT ID: NCT05741255 Completed - Clinical trials for Acceptance and Commitment Therapy, Mental Health, Cognitive Impairment,Colorectal Cancer

Effect of Acceptance and Commitment Therapy Based Interventions on Mental Health and Cognitive Impairment for Patients With Advanced Colorectal Cancer

Start date: January 5, 2022
Phase: N/A
Study type: Interventional

The present study aims to: Determine the effect of acceptance and commitment therapy-based interventions on mental health and cognitive impairment for patients with advanced colorectal cancer. Research Hypothesis: Cancer patients who receive acceptance and commitment therapy-based interventions will exhibit better mental health and lower cognitive impairments than those who didn't receive it.

NCT ID: NCT05741047 Completed - Clinical trials for Mild Cognitive Impairment

Comparative Effects of a2 Skim Milk on Mild Cognitive Impairment in Older Adults

Start date: March 7, 2023
Phase: N/A
Study type: Interventional

The aim of the study is to compare the effects of powdered skim milk containing A2 β-casein only versus conventional powdered skim milk containing A1 and A2 β-casein milk on cognition, inflammation, and dietary intake in adults aged 65-75 years.

NCT ID: NCT05739357 Completed - Clinical trials for Postoperative Cognitive Dysfunction

Neurocognitive Function After Carotid Thrombendarterectomy

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

Previous studies did not reach a consensus on the influence of the type of anesthesiologic procedure and monitoring, during carotid thrombendarterectomy, on perioperative complications and cognitive outcomes. The aim of this study is the optimization of brain perfusion during the vascular carotid clamp using multimodal monitoring. We assume that standardized monitoring techniques and a better selection of cognitive tests will allow a more accurate assessment of subclinical cognitive deficits.

NCT ID: NCT05737459 Completed - Clinical trials for Cognitive Impairment

Sedation and Postoperative Cognitive Functions

Start date: May 1, 2022
Phase:
Study type: Observational [Patient Registry]

Patients over the age of 65 who underwent elective surgery for a hip fracture and were sedated during spinal anesthesia were included in the study. Patients who were given ketamine and dexmedetomidine for sedation were included in the study. The Mini Mental Status Tests of the patients measured on the first and third days of the operation in the preoperative period were determined from the hospital records and recorded.

NCT ID: NCT05735353 Completed - Cognitive Decline Clinical Trials

Sleep, Diet, Exercise and Older Persons

Start date: January 17, 2023
Phase: N/A
Study type: Interventional

To examine the impacts of a cognitive yoga program and circuit resistance training on cognitive and physical performance with nutrition and sleep as modulating factors in healthy, older adults.

NCT ID: NCT05726565 Completed - Clinical trials for Cognitive Impairment

Impact of Cardiac Rehabilitation on Acute Heart Failure Patients With Cognitive Impairment

Start date: March 1, 2015
Phase:
Study type: Observational

In heart failure patients, neuropsychological disorders have been prospectively linked to frequent hospitalizations, recurrent cardiac events, and mortality. Cognitive dysfunction is also a frequent comorbidity in heart failure (HF) patients. The benefit of cardiac rehabilitation between patients with cognitive dysfunction and patients without cognitive dysfunction is unknown. Investigators hypothesize that patients with cognitive dysfunction benefit more from cardiac rehabilitation programs than patients without cognitive dysfunction.

NCT ID: NCT05725889 Completed - Clinical trials for Diabetes Mellitus, Type 2

Detection of Visual-Auditory Reaction Rates in Individuals With Type 2 Diabetes

Start date: July 15, 2021
Phase:
Study type: Observational

Background: The primary purpose of our study was to understand the damage in the peripheral nerves of patients with diabetes and to determine the change in patients' reaction rates and perceptions by the age groups, duration of diabetes, fasting plasma glucose and HbA1c values, and compare these with those of the healthy individuals. Methods: This study was carried out at the Baskent University Hospital Endocrinology and Metabolic Diseases Outpatient Clinic. A total of 64 patients diagnosed with type 2 diabetes and 64 healthy controls were included in the study. Finger tapping, visual, and auditory reaction time tests were performed on the subjects, respectively. The subjects' fasting plasma glucose and HbA1c levels, and the duration of their diabetes were recorded. Analyses were performed using the SPSS version 25. Differences were considered statistically significant when the p-value is <0.05.

NCT ID: NCT05723822 Completed - Clinical trials for Mild Cognitive Impairment

Effects of Walkasins on Gait Speed of Individuals With Mild Cognitive Impairments

Start date: February 16, 2023
Phase: N/A
Study type: Interventional

The primary aim of this pilot study is to investigate the effect of Walkasins, a wearable lower-limb sensory prosthesis, on the gait speed and balance function of participants with mild cognitive impairment as measured by the Saint Louis University Mental Status (SLUMS) Examination.